587 related articles for article (PubMed ID: 23796982)
1. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
Hu Y; Cheng X; Cao F; Huang A; Tavis JE
Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
[TBL] [Abstract][Full Text] [Related]
2. Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity.
Lu G; Lomonosova E; Cheng X; Moran EA; Meyers MJ; Le Grice SF; Thomas CJ; Jiang JK; Meck C; Hirsch DR; D'Erasmo MP; Suyabatmaz DM; Murelli RP; Tavis JE
Antimicrob Agents Chemother; 2015 Feb; 59(2):1070-9. PubMed ID: 25451058
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.
Tavis JE; Cheng X; Hu Y; Totten M; Cao F; Michailidis E; Aurora R; Meyers MJ; Jacobsen EJ; Parniak MA; Sarafianos SG
PLoS Pathog; 2013 Jan; 9(1):e1003125. PubMed ID: 23349632
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.
Lu G; Villa JA; Donlin MJ; Edwards TC; Cheng X; Heier RF; Meyers MJ; Tavis JE
Antiviral Res; 2016 Nov; 135():24-30. PubMed ID: 27693161
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and cytotoxicity in cell culture of novel α-hydroxytropolone inhibitors of hepatitis B virus ribonuclease H.
Lomonosova E; Daw J; Garimallaprabhakaran AK; Agyemang NB; Ashani Y; Murelli RP; Tavis JE
Antiviral Res; 2017 Aug; 144():164-172. PubMed ID: 28633989
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity.
Cai CW; Lomonosova E; Moran EA; Cheng X; Patel KB; Bailly F; Cotelle P; Meyers MJ; Tavis JE
Antiviral Res; 2014 Aug; 108():48-55. PubMed ID: 24858512
[TBL] [Abstract][Full Text] [Related]
7. Chemical Approaches to Inhibiting the Hepatitis B Virus Ribonuclease H.
Tavis JE; Zoidis G; Meyers MJ; Murelli RP
ACS Infect Dis; 2019 May; 5(5):655-658. PubMed ID: 29565562
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Enzymatic and Cell Culture-Based Assays for Measuring Activity of HBV RNaseH Inhibitors.
Lomonosova E; Tavis JE
Methods Mol Biol; 2017; 1540():179-192. PubMed ID: 27975316
[TBL] [Abstract][Full Text] [Related]
9. The hepatitis B virus ribonuclease H as a drug target.
Tavis JE; Lomonosova E
Antiviral Res; 2015 Jun; 118():132-8. PubMed ID: 25862291
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors.
Lomonosova E; Zlotnick A; Tavis JE
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956427
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles.
Edwards TC; Lomonosova E; Patel JA; Li Q; Villa JA; Gupta AK; Morrison LA; Bailly F; Cotelle P; Giannakopoulou E; Zoidis G; Tavis JE
Antiviral Res; 2017 Jul; 143():205-217. PubMed ID: 28450058
[TBL] [Abstract][Full Text] [Related]
12. Purification and enzymatic characterization of the hepatitis B virus ribonuclease H, a new target for antiviral inhibitors.
Villa JA; Pike DP; Patel KB; Lomonosova E; Lu G; Abdulqader R; Tavis JE
Antiviral Res; 2016 Aug; 132():186-95. PubMed ID: 27321664
[TBL] [Abstract][Full Text] [Related]
13. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
[TBL] [Abstract][Full Text] [Related]
15. Amide-containing α-hydroxytropolones as inhibitors of hepatitis B virus replication.
Li Q; Lomonosova E; Donlin MJ; Cao F; O'Dea A; Milleson B; Berkowitz AJ; Baucom JC; Stasiak JP; Schiavone DV; Abdelmessih RG; Lyubimova A; Fraboni AJ; Bejcek LP; Villa JA; Gallicchio E; Murelli RP; Tavis JE
Antiviral Res; 2020 May; 177():104777. PubMed ID: 32217151
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice.
Long KR; Lomonosova E; Li Q; Ponzar NL; Villa JA; Touchette E; Rapp S; Liley RM; Murelli RP; Grigoryan A; Buller RM; Wilson L; Bial J; Sagartz JE; Tavis JE
Antiviral Res; 2018 Jan; 149():41-47. PubMed ID: 29129708
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HBV replication by N-hydroxyisoquinolinedione and N-hydroxypyridinedione ribonuclease H inhibitors.
Edwards TC; Mani N; Dorsey B; Kakarla R; Rijnbrand R; Sofia MJ; Tavis JE
Antiviral Res; 2019 Apr; 164():70-80. PubMed ID: 30768944
[TBL] [Abstract][Full Text] [Related]
18. Efficient Inhibition of Hepatitis B Virus (HBV) Replication and cccDNA Formation by HBV Ribonuclease H Inhibitors during Infection.
Chauhan R; Li Q; Woodson ME; Gasonoo M; Meyers MJ; Tavis JE
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0146021. PubMed ID: 34516242
[TBL] [Abstract][Full Text] [Related]
19. Shedding light on RNaseH: a promising target for hepatitis B virus (HBV).
Edwards TC; Ponzar NL; Tavis JE
Expert Opin Ther Targets; 2019 Jul; 23(7):559-563. PubMed ID: 31084514
[No Abstract] [Full Text] [Related]
20. HBV replication inhibitors.
Pierra Rouviere C; Dousson CB; Tavis JE
Antiviral Res; 2020 Jul; 179():104815. PubMed ID: 32380149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
